Randomization to once-daily stavudine extended release/lamivudine/efavirenz versus a more frequent regimen improves adherence while maintaining viral suppression.

Source:http://linkedlifedata.com/resource/pubmed/id/18547903

Download in:

View as

General Info

PMID
18547903